John Edward Hamer's most recent trade in AbCellera Biologics Inc was a trade of 162,649 Common Shares done at an average price of $17.0 . Disclosure was reported to the exchange on Aug. 31, 2021.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| AbCellera Biologics Inc | John Edward Hamer | Director | Sale of securities on an exchange or to another person at price $ 16.95 per share. | 31 Aug 2021 | 162,649 | 266,213 | - | 17.0 | 2,756,901 | Common Shares |
| AbCellera Biologics Inc | John Edward Hamer | Director | Sale of securities on an exchange or to another person at price $ 16.93 per share. | 31 Aug 2021 | 137,351 | 128,862 | - | 16.9 | 2,325,352 | Common Shares |
| AbCellera Biologics Inc | John Edward Hamer | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 18 Jun 2021 | 5,000,000 | 24,105,761 | - | 0 | Common Shares | |
| AbCellera Biologics Inc | John Edward Hamer | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 18 Jun 2021 | 73,892 | 73,892 | - | 0 | Common Shares | |
| AbCellera Biologics Inc | John Edward Hamer | Director, Ten Percent Owner | 11 Dec 2020 | 29,076,350 | 29,076,350 | - | - | Common Shares | ||
| AbCellera Biologics Inc | John Edward Hamer | Director, Ten Percent Owner | 11 Dec 2020 | 2,105,264 | 0 | - | - | Series A1 Preferred Shares | ||
| AbCellera Biologics Inc | John Edward Hamer | Director, Ten Percent Owner | 11 Dec 2020 | 802,371 | 0 | - | - | Series A2 Preferred Shares | ||
| AbCellera Biologics Inc | John Edward Hamer | Director, Ten Percent Owner | 11 Dec 2020 | 29,411 | 29,105,761 | - | - | Common Shares |